Skip to main content

ADVERTISEMENT

Podcasts

Ebonie Vincent, DPM
Podcasts
11/17/2023
Ebonie Vincent, DPM
In this podcast, Dr. Vincent shares her insights and experience with special considerations in treating onychomycosis.
In this podcast, Dr. Vincent shares her insights and experience with special considerations in treating onychomycosis.
In this podcast, Dr. Vincent...
11/17/2023
Podiatry Today
Ebonie Vincent, DPM
Sponsored Podcast
11/17/2023
Ebonie Vincent, DPM
In this podcast, Dr. Vincent shares her insights and experience with treating onychomycosis.
In this podcast, Dr. Vincent shares her insights and experience with treating onychomycosis.
In this podcast, Dr. Vincent...
11/17/2023
Podiatry Today
Ebonie Vincent, DPM
Sponsored Podcast
11/17/2023
Ebonie Vincent, DPM
In this podcast, Dr. Vincent shares her insights and experience with educating patients about onychomycosis.
In this podcast, Dr. Vincent shares her insights and experience with educating patients about onychomycosis.
In this podcast, Dr. Vincent...
11/17/2023
Podiatry Today
Rakesh Jain, MD, MPH.
Podcasts
11/15/2023
In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
In this podcast, Rakesh Jain,...
11/15/2023
Psych Congress Network
Suzuki
Wound Care Q&A
11/10/2023
Kazu Suzuki, DPM, CWS
Dr. Suzuki touches down on hyperbaric oxygen therapy indications, and the experience he has had with this modality.
Dr. Suzuki touches down on hyperbaric oxygen therapy indications, and the experience he has had with this modality.
Dr. Suzuki touches down on...
11/10/2023
Podiatry Today
Podcasts
11/09/2023

Featuring Edward Loftus, MD

Featuring Edward Loftus, MD
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details...
11/09/2023
Pharmacy Learning Network
IBD Drive time logo
Podcast
11/08/2023
Dr Raymond Cross quizzes Dr Francis Farraye on the latest guidance regarding vaccinations against COVID-19 and RSV in this episode of IBD DriveTime.
Dr Raymond Cross quizzes Dr Francis Farraye on the latest guidance regarding vaccinations against COVID-19 and RSV in this episode of IBD DriveTime.
Dr Raymond Cross quizzes Dr...
11/08/2023
Advances in Inflammatory Bowel Disease Network
Fleischmann
Podcast
11/07/2023
Dr Fleishmann reviews a post hoc analysis he and colleagues conducted of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.
Dr Fleishmann reviews a post hoc analysis he and colleagues conducted of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.
Dr Fleishmann reviews a post hoc...
11/07/2023
Rheumatology & Arthritis
Podcasts
11/07/2023

Featuring Christina Ha, MD

Featuring Christina Ha, MD
Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about biosimilar therapies, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.
Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about biosimilar therapies, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.
Guest Christina Ha, MD, from the...
11/07/2023
Pharmacy Learning Network
Podcasts
11/06/2023

Featuring Steven Peskin, MD, CEO, SRP Advisors

Featuring Steven Peskin, MD, CEO, SRP...
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general...
11/06/2023
First Report Managed Care